(Q38248192)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25208981%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

review article

1 reference

title

Targeting Epstein-Barr virus infection as an intervention against multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25208981%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25208981%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

author name string

P Sundström

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25208981%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

O Andersen

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25208981%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

language of work or name

English

0 references

publication date

11 September 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25208981%20AND%20SRC:MED&resulttype=core&format=json

Acta Neurologica Scandinavica

16 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25208981%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

volume

131

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25208981%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25208981%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

page(s)

69-79

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25208981%20AND%20SRC:MED&resulttype=core&format=json

The essential role of Epstein-Barr virus in the pathogenesis of multiple sclerosis

16 February 2020

cites work

1 reference

Epstein-barr virus infection and multiple sclerosis: a review

21 January 2018

1 reference

Geography of hospital admissions for multiple sclerosis in England and comparison with the geography of hospital admissions for infectious mononucleosis: a descriptive study

21 January 2018

1 reference

Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study

21 January 2018

1 reference

An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study

21 January 2018

1 reference

Multiple sclerosis is linked to Epstein-Barr virus infection

21 January 2018

1 reference

Epstein-Barr virus and multiple sclerosis: interaction with HLA.

21 January 2018

1 reference

Preventing and curing multiple sclerosis by controlling Epstein-Barr virus infection.

21 January 2018

1 reference

Epstein-Barr virus and multiple sclerosis: association or causation?

21 January 2018

1 reference

Epstein-Barr virus is a necessary causative agent in the pathogenesis of multiple sclerosis: yes.

21 January 2018

1 reference

Epstein-Barr virus is a necessary causative agent in the pathogenesis of multiple sclerosis: no.

21 January 2018

1 reference

Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis

21 January 2018

1 reference

Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up

21 January 2018

1 reference

Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis

21 January 2018

1 reference

The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta-analysis

21 January 2018

1 reference

High seroprevalence of Epstein-Barr virus in children with multiple sclerosis

21 January 2018

1 reference

Consensus definitions proposed for pediatric multiple sclerosis and related disorders

21 January 2018

1 reference

Infectious mononucleosis in Greenland: a disease of the non-indigenous population.

21 January 2018

1 reference

Prevalence of Epstein-Barr virus in Japan: trends and future prediction

21 January 2018

1 reference

Epstein-Barr virus (EBV) infection in infancy

21 January 2018

1 reference

Studies on the epidemiology of child infections in the Bari area (south Italy). VII. Epidemiology of Epstein-Barr virus infections

21 January 2018

1 reference

21 January 2018

Infectious Mononucleosis

1 reference

Epstein-Barr virus-recent advances

21 January 2018

1 reference

Soluble factors produced by activated CD4+ T cells modulate EBV latency

21 January 2018

1 reference

Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.

21 January 2018

1 reference

A cohort study among university students: identification of risk factors for Epstein-Barr virus seroconversion and infectious mononucleosis

21 January 2018

1 reference

Prevalence, incidence and persistence of EB virus antibody in young adults

21 January 2018

1 reference

Genome-wide analysis of wild-type Epstein-Barr virus genomes derived from healthy individuals of the 1,000 Genomes Project

21 January 2018

1 reference

Sex ratio of infectious mononucleosis and possible relevance to multiple sclerosis.

21 January 2018

1 reference

A case-control study of multiple sclerosis

21 January 2018

1 reference

Epidemiological investigation of the association between infectious mononucleosis and multiple sclerosis

21 January 2018

1 reference

Multiple sclerosis after infectious mononucleosis: record linkage study

21 January 2018

1 reference

Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis

21 January 2018

1 reference

An Updated Meta-Analysis of Risk of Multiple Sclerosis following Infectious Mononucleosis

21 January 2018

1 reference

Association of infectious mononucleosis with multiple sclerosis. A population-based study.

21 January 2018

1 reference

Selective association of multiple sclerosis with infectious mononucleosis.

21 January 2018

1 reference

Primary Infection with Epstein-Barr Virus in Infants in the United States: Clinical and Serologic Observations

21 January 2018

1 reference

Persistence of the Epstein-Barr virus and the origins of associated lymphomas

21 January 2018

1 reference

Higher incidence of Epstein-Barr virus-induced lymphocyte transformation in multiple sclerosis

21 January 2018

1 reference

Clinical and laboratory presentation of EBV positive infectious mononucleosis in young adults

21 January 2018

1 reference

The effect of infections on susceptibility to autoimmune and allergic diseases

21 January 2018

1 reference

Multiple sclerosis and infectious childhood diseases.

21 January 2018

1 reference

Childhood infections and risk of multiple sclerosis

21 January 2018

1 reference

Multiple sclerosis in stepsiblings: recurrence risk and ascertainment

21 January 2018

1 reference

Modest familial risks for multiple sclerosis: a registry-based study of the population of Sweden

21 January 2018

1 reference

Epstein-Barr virus nuclear antigen-1 B-cell epitopes in multiple sclerosis twins.

21 January 2018

1 reference

Radiologically isolated syndrome--incidental magnetic resonance imaging findings suggestive of multiple sclerosis, a systematic review.

21 January 2018

1 reference

Asymptomatic visual loss in multiple sclerosis.

21 January 2018

1 reference

Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and systemic lupus erythematosus

21 January 2018

1 reference

Epstein-Barr virus in systemic autoimmune diseases

21 January 2018

1 reference

Environmental factors and their timing in adult-onset multiple sclerosis

21 January 2018

1 reference

Increased CSF sulfatide levels and serum glycosphingolipid antibody levels in healthy siblings of multiple sclerosis patients

21 January 2018

1 reference

Genetic aspects of vitamin D receptor and metabolism in relation to the risk of multiple sclerosis.

21 January 2018

1 reference

Risk associated behavior in premorbid multiple sclerosis: A case-control study

21 January 2018

1 reference

Evidence of shared Epstein-Barr viral isolates between sexual partners, and low level EBV in genital secretions

21 January 2018

1 reference

Sexual history and Epstein-Barr virus infection

21 January 2018

1 reference

Epstein-Barr virus can infect rabbits by the intranasal or peroral route: an animal model for natural primary EBV infection in humans

21 January 2018

1 reference

Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students

21 January 2018

1 reference

Antibodies against Epstein-Barr nuclear antigen (EBNA) in multiple sclerosis CSF, and two pentapeptide sequence identities between EBNA and myelin basic protein

21 January 2018

1 reference

Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis

21 January 2018

1 reference

Latent and lytic Epstein-Barr virus replication strategies

21 January 2018

1 reference

Replication of Epstein-Barr viral DNA.

21 January 2018

1 reference

Plasma viral load of Epstein-Barr virus and risk of multiple sclerosis

21 January 2018

1 reference

Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis.

21 January 2018

1 reference

Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain

21 January 2018

1 reference

Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration

21 January 2018

1 reference

Association between clinical disease activity and Epstein-Barr virus reactivation in MS.

21 January 2018

1 reference

Epstein-Barr virus and disease activity in multiple sclerosis

21 January 2018

1 reference

Epstein-Barr virus neutralizing and early antigen antibodies in multiple sclerosis

21 January 2018

1 reference

Acyclovir treatment of relapsing-remitting multiple sclerosis. A randomized, placebo-controlled, double-blind study.

21 January 2018

1 reference

A randomized, double-blind, placebo-controlled MRI study of anti-herpes virus therapy in MS.

21 January 2018

1 reference

A randomized clinical trial of valacyclovir in multiple sclerosis

21 January 2018

1 reference

Acyclovir levels in serum and cerebrospinal fluid after oral administration of valacyclovir.

21 January 2018

1 reference

Rituximab in relapsing and progressive forms of multiple sclerosis: a systematic review

21 January 2018

1 reference

Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial

21 January 2018

1 reference

A mechanistic, stochastic model helps understand multiple sclerosis course and pathogenesis

21 January 2018

1 reference

Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score

21 January 2018

1 reference

Pernicious anemia - genetic insights

21 January 2018

1 reference

Epstein-Barr virus vaccine for the prevention of infectious mononucleosis--and what else?

21 January 2018

1 reference

Infectious mononucleosis in university students in the United kingdom: evaluation of the clinical features and consequences of the disease

21 January 2018

1 reference

Chronic fatigue syndrome after infectious mononucleosis in adolescents

21 January 2018

1 reference

Therapeutic vaccination against the rhesus lymphocryptovirus EBNA-1 homologue, rhEBNA-1, elicits T cell responses to novel epitopes in rhesus macaques.

21 January 2018

1 reference

A virus-like particle-based Epstein-Barr virus vaccine

21 January 2018

1 reference

A phase I trial of epstein-barr virus gp350 vaccine for children with chronic kidney disease awaiting transplantation.

21 January 2018

1 reference

Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults

21 January 2018

1 reference

A novel tetrameric gp350 1-470 as a potential Epstein-Barr virus vaccine.

21 January 2018

1 reference

Subacute sclerosing panencephalitis (SSPE) the story of a vanishing disease

21 January 2018

1 reference

A brief history of hepatitis milestones

21 January 2018

1 reference

The role of Human Papilloma Virus (HPV) vaccination in the prevention of anal cancer in individuals with Human Immunodeficiency Virus-1 (HIV-1) infection

21 January 2018

1 reference

Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel

21 January 2018

1 reference

Epstein-Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank samples

21 January 2018

1 reference

Characteristics of Hodgkin's Lymphoma after Infectious Mononucleosis

21 January 2018

1 reference

Multiple Sclerosis After Infectious Mononucleosis

21 January 2018

1 reference

Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis

21 January 2018

1 reference

Incidence of CSF abnormalities in siblings of multiple sclerosis patients and unrelated controls

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/ANE.12294

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25208981%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference